induced a strong (>5-fold) increase in the mRNA levels of the recently described hyaluronidase TMEM2. Lentiviral shRNA-mediated gene knockdown promoted a reduction of TMEM2 protein expression. However, TMEM2 knockdown did not restore barrier function (as measured by TEER) or HA levels (as measured by HABP-mediated fluorescence). CONCLUSION: TMEM2 does not seem to have an independent role in the IL6-mediated pathway of vascular leakage or HA loss in HUVEC monolayers. It is possible that TMEM2 requires the presence of another gene to mediate this pathway of endothelial cell leakage and thus preeclampsia. This will be the focus of future studies.
OBJECTIVE: Many women describe symptoms of memory loss or inattention during pregnancy and the early postpartum period ("pregnancy brain"). Data on the effect of pregnancy on cognitive function has been mixed. We sought to objectively evaluate executive function (EF) in the early pregnancy and postpartum period. STUDY DESIGN: Women with singleton gestations were recruited in the first trimester of pregnancy as part of a larger IRB approved prospective trial. EF performance was assessed in the first trimester and at 6 weeks postpartum using the Trail Making Test (TMT) of the Delis-Kaplan Executive Function System, the Stop Signal Task (SST), and the Delay Discounting Task (DDT). Perceived problems with EF were measured using the Behavior Rating Inventory of Executive Function e Adult self-report (BRIEF-A). Mental health was measured using the Euro Quality of Life (EQ-5D-3L) and Adult Self Report (ASR). Changes in EF were evaluated by paired student's ttests. RESULTS: 102 women completed EF assessment at both time points. Mean scores on the TMT and BRIEF were within average range. No self-reported differences in EF were observed between time points. Objective EF measures showed more impulsive behavior (p < 0.05), but improved cognitive flexibility (p < 0.0001) postpartum compared to the first trimester. Neither self-reported "overall health" nor the number of women reporting clinically significant levels of mental health-related symptoms differed between visits. CONCLUSION: Postpartum EF performance was worse than that in the first trimester, with the exception of cognitive flexibility, without subjective changes in health. These data suggest that cognitive function varies across pregnancy and that at least in the early postpartum period there are observable cognitive deficits. More study is needed to further longitudinally examine EF beyond 6 weeks postpartum.
OBJECTIVE: Lactation has been shown to have many benefits in longterm maternal health including improvement in cardiovascular function, weight and adiposity. Oxytocin may play a role in these benefits. Our objective was to examine these effects by using a transgenic mouse model with deficient lactation due to lack of the oxytocin gene (Oxt -/-). STUDY DESIGN: 2-3 month old female B629sF2/J mice were bred and allowed to deliver. They were randomized to lactating (L, n¼10-16), and non-lactating (NL, n¼10-12) groups. As a comparison, our lab also used a transgenic mouse model with deficient lactation due to lack of the oxytocin gene (Oxt -/-). The transgenic mice were bred, they delivered (KO PP, n¼10-16), but were unable to lactate. All groups (KO PP, L and NL) underwent computed tomography (CT) scans to measure visceral (VAT) and subcutaneous adiposity (SAT) before breeding and then at 2 and 6 months post partum. Mice were then sacrificed, excised visceral fat was weighed, and serum was collected. ELISA was used to determine the serum concentration of triglycerides (TG), insulin, total cholesterol, LDL and HDL. Insulin along with fasting glucose levels was used to calculate HOMA-IR. One-way and Repeated Measures ANOVAS with post hoc comparison tests were used for statistical analysis (statistical significance P<0.05). RESULTS: At 6 months post delivery, the dam weight and adiposity (percent of excised fat from total body weight) was significantly lower in the L group compared to both the NL and KO PP groups (weight P¼0.04 for all, adiposity L vs NL P¼0.01, L vs KO PP P¼0.03). The VAT and SAT measured on CT scans were significantly lower in the L group when compared to both NL and KO PP groups at 6 months post delivery (P<0.05, Figure) . Fasting glucose was significantly lower in the L group compared to NL group (P¼0.03).
Poster Session V OBJECTIVE: Quantification of blood loss (using calibrated drapes and/ or weighing of clots and blood soaked materials) has been touted as a means to improve the recognition and treatment of postpartum hemorrhage (PPH). However, the maternal physiologic response to blood loss depends on total blood volume (TBV) prior to delivery, and the clinical significance of quantified blood loss (QBL) will depend in part upon the degree of blood volume expansion in pregnancy (where TBV ¼ plasma volume + red cell volume). Prior small studies have demonstrated significant variation in late pregnancy TBV in varied clinical contexts. The purpose of this study was to assess the variation of TBV expansion in a cohort of women at risk for preeclampsia. STUDY DESIGN: TBV was calculated from longitudinal measurements of PV prior to conception (follicular phase) and in late pregnancy (32-36 weeks) in a cohort of women at risk for preeclampsia due to nulliparous status or prior preeclampsia. TBV was calculated for all women by direct measurement of PV using Evan's blue dye injection, and hematocrit. The hematocrit was corrected using a generally accepted "whole body/peripheral hematocrit ratio" of 0.9. Thus, TBV ¼ Plasma Volume/(1-{hematocrit x 0.9}). RESULTS: Figure 1 shows the median and range of PV expansion from pre-conception to late pregnancy in women who were normotensive at delivery (n¼52), and in those who developed hypertensive disorders (preterm preeclampsia {n¼7}, term preeclampsia {n¼5}, gestational hypertension {n¼10}). PV expansion in the entire cohort ranged from -1% to 97%, with an overall median of 52%. Figure 2 demonstrates the median and range of total PV and TBV in late pregnancy for each group. Third trimester total PV and TBV ranged from 2380ml to 6050ml (median ¼ 3796ml), and from 3852ml to 8391ml (median 5476ml), respectively, in the entire cohort. CONCLUSION: Late pregnancy TBV (largely driven by PV expansion), is higher in normal pregnancies than in those complicated by hypertensive disorders, though there is substantial individual variation across all groups. The maternal physiologic response to a given volume of blood loss will be unpredictable as a result of such variation. Thus, despite frequent focus on blood loss quantification methods (QBL) as a means to improve maternal care, the maternal physiologic response-not the specific volume of blood lost, is likely to be most crucial in the timely recognition and management of PPH. OBJECTIVE: Increased ectopic lipid stores [intrahepatic (IHL) and intramyocellular (IMCL)] in nonpregnant adults are associated with reduced insulin sensitivity. Further, in women with diabetes, reduced hepatic insulin sensitivity is associated with greater birthweight in the offspring. We examined whether these associations were present in late pregnancy among women without pregestational diabetes.
